Welcome to Canndr® - the future of medicinal cannabis care in the UK.
Canndr® is the brainchild of two industry leaders, BRITISH CANNABIS® and AGI Health®. While it operates independently, its inception was inspired by their shared vision to shatter stigmas, empower patients, and usher the medicinal cannabis industry into a new era of innovation. Canndr® is more than just an app; it’s a movement.
BRITISH CANNABIS®, a pioneer in the cannabis industry, brings over a decade of unrivaled expertise in cannabis consulting, product development, regulatory compliance, and research. AGI Health® is a leader in AI technology, dedicated to transforming healthcare through data-driven solutions. Their combined knowledge and expertise have set the foundation for Canndr’s unique approach, blending cannabis expertise with AI ingenuity.
At the heart of Canndr®, we believe in the transformative power of technology in healthcare. We’ve harnessed groundbreaking proprietary AI technology to analyze patient data and provide doctors with ultra-accurate, hyper-personalized cannabis treatment plans. For patients, we serve as an all-in-one platform – a directory, social network, education hub, and intake system.
Our mission is to empower patients and transform the status quo, creating a global gold standard for cannabis care. Our app is designed to tackle the industry’s challenges head-on, always putting patients first. From empowering patients with comprehensive product information to providing doctors with the tools they need, we are reshaping the medicinal cannabis landscape.
Education is at the core of our ethos. We are committed to combating misinformation and stigma surrounding cannabis and provide users with evidence-based research articles, webinars, interactive quizzes, beginner guides, and more. Knowledge is power, and we aim to put that power in the hands of the people.
We are also committed to data-driven innovation. With users’ consent, we collect anonymous data to guide doctors’ prescribing, shape policy and regulation, drive product R&D, and publish groundbreaking studies. We believe in turning data into action, providing tangible value to users and improving care on a global scale.